Maralixibat Chloride
- Generic Name
- Maralixibat Chloride
- Brand Names
- Livmarli
Overview
No overview information available.
Background
No background information available.
Indication
用于治疗1岁及以上阿拉杰里综合征（Alagille Syndrome，ALGS）患者的胆汁淤积性瘙痒。 Alagille综合征（罕见病）是一种罕见遗传性疾病，因胆管异常狭窄、畸形和数量减少，导致胆汁在肝脏蓄积，从而引发进行性肝病。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/01/05 | N/A | Recruiting |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|---|---|---|---|---|---|---|---|
EMEA/H/C/005857 | Netherlands | Orphan | Authorised | 2022/12/09 | 2022/10/13 | 7 |
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字HJ20230061 | 口服溶液剂 | 迈芮倍 | 30ml：285mg（按C₄₀H₅₆N₃O₄S计） | Chemical Drug | Approved | 2023/05/29 | Import |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath